CordovaCann (LVRLF) Net Income towards Common Stockholders (2017 - 2020)

CordovaCann (LVRLF) recorded quarterly Net Income towards Common Stockholders of -$77278.4 in Q1 2020, up 82.19% quarter-over-quarter from -$433998.8 in Q4 2019, and up 91.93% on a YoY basis from -$40264.0 in Q2 2019.

CordovaCann (LVRLF) Net Income towards Common Stockholders (2017 - 2020) Analysis & Trends

CordovaCann's Net Income towards Common Stockholders history runs 4 years deep, the most recent figure standing at -$77278.4 for Q1 2020.

  • In Q1 2020, Net Income towards Common Stockholders rose 91.93% year-over-year to -$77278.4; the TTM figure through Jun 2022 stood at -$77278.4 (up 84.89% YoY), while the FY2025 annual figure was -$147270.5, up 68.93% from the prior year.
  • Net Income towards Common Stockholders was -$77278.4 for Q1 2020 at CordovaCann, up from -$433998.8 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$15834.1 in Q1 2017 to a low of -$2.6 million in Q1 2018.
  • Historically, Net Income towards Common Stockholders has averaged -$776162.7 across 4 years, with a median of -$600293.2 in 2019.
  • The sharpest annual moves came in 2018 and 2020: Net Income towards Common Stockholders tumbled 16631.29% in 2018, then soared 91.93% in 2020.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at -$19776.5 in 2017, then plunged by 6081.05% to -$1.2 million in 2018, then jumped by 64.5% to -$433998.8 in 2019, then jumped by 82.19% to -$77278.4 in 2020.
  • The last three Net Income towards Common Stockholders figures came in at -$77278.4 (Q1 2020), -$433998.8 (Q4 2019), and -$600293.2 (Q3 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 CordovaCann - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -77,278.41
Dec 31, 2019 -433,998.84
Sep 30, 2019 -600,293.23
Jun 30, 2019 -1.35 Mn
Mar 31, 2019 -957,507.50
Dec 31, 2018 -1.22 Mn
Sep 30, 2018 -678,871.70
Jun 30, 2018 -528,084.05
Mar 31, 2018 -2.65 Mn
Sep 30, 2017 -19,776.48
Mar 31, 2017 -15,834.13